YNIOS Pharma, a biotech start-up, develops new oral and parenteral treatments to treat pathologies involving inflammation and restore homeostasis.
The company is developing treatments for Systemic Inflammatory Response Syndrome (SIRS) and chronic inflammatory diseases, using a proprietary ionic compound that targets innate immune pathways.